{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T11:00:10Z","timestamp":1770721210598,"version":"3.49.0"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T00:00:00Z","timestamp":1611273600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1K08 AR072757-01"],"award-info":[{"award-number":["1K08 AR072757-01"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Patients with autoimmune disorders (AD) have altered cancer risks compared to the general population. Systemic lupus erythematosus and multiple sclerosis lead to a heightened risk for hematological malignancies and decreased risk for breast, ovarian, and prostate malignancies. Often patients with autoimmune disease have dysregulated antiviral immune responses, including against oncogenic viruses. To uncover the relationship between viral incidence and cancer risk in the context of autoimmune disease, we extracted electronic health records (EHR) from Vanderbilt University. ICD-9\/10 codes and laboratory values were collected for hematological, lung, anal-vaginal, thyroid, hepatobiliary, bladder, prostate, and breast cancers; and viruses including Epstein Barr virus (EBV), Human papilloma virus (HPV), and Hepatitis A\/B\/C (Hep). Only viral infections that led to a physician visit or laboratory test were entered into the EMR; therefore, only clinically relevant cases were noted and considered positive in this study. The relationship between virus infection and cancer in an SLE cohort (SLE-cases n = 2,313, and SLE-controls n = 5,702) and an MS cohort (MS-case n = 7,277, MS-control n = 7,277) was examined by multilinear logistic regression. Viral infection was strongly associated with increased risk for cancer overall. SLE and MS patients were more susceptible to all viral infections. MS patients trended toward increased risk for cancers overall, while decreased risk for hormone-based cancers in SLE patients non-significantly reduced their risk for overall cancer. Both SLE and MS patients had increased clinically relevant EBV infection, which was associated with risk for hematological cancers. Preventing viral infections by vaccination may be especially helpful in controlling risk for cancer in SLE and MS patients.<\/jats:p>","DOI":"10.1371\/journal.pone.0243150","type":"journal-article","created":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T22:51:02Z","timestamp":1611355862000},"page":"e0243150","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Contribution of viral infection to risk for cancer in systemic lupus erythematosus and multiple sclerosis"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4575-9841","authenticated-orcid":true,"given":"Deborah K.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaylia M.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3205-640X","authenticated-orcid":true,"given":"Brian D.","family":"Poole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0860-1420","authenticated-orcid":true,"given":"Matthew D.","family":"Montierth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3791-9606","authenticated-orcid":true,"given":"Vera M.","family":"Todd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"April","family":"Barnado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3344-0013","authenticated-orcid":true,"given":"Mary F.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2021,1,22]]},"reference":[{"issue":"6","key":"pone.0243150.ref001","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1177\/0961203309102556","article-title":"Lupus and cancer","volume":"18","author":"M Gayed","year":"2009","journal-title":"Lupus"},{"issue":"6","key":"pone.0243150.ref002","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/art.1780390625","article-title":"Malignancy in systemic lupus erythematosus","volume":"39","author":"M Abu-Shakra","year":"1996","journal-title":"Arthritis and rheumatism"},{"issue":"4","key":"pone.0243150.ref003","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/ard.51.4.437","article-title":"Increased risk of cancer in patients with systemic lupus erythematosus","volume":"51","author":"T Pettersson","year":"1992","journal-title":"Annals of the rheumatic diseases"},{"issue":"9","key":"pone.0243150.ref004","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s10096-014-2098-7","article-title":"Infections and systemic lupus erythematosus","volume":"33","author":"S Esposito","year":"2014","journal-title":"European journal of clinical microbiology & infectious diseases: official publication of the European Society of Clinical Microbiology"},{"issue":"4","key":"pone.0243150.ref005","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1191\/0961203302lu170oa","article-title":"The nature and outcome of infection in systemic lupus erythematosus","volume":"11","author":"DD Gladman","year":"2002","journal-title":"Lupus"},{"issue":"1","key":"pone.0243150.ref006","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1136\/annrheumdis-2012-202099","article-title":"Lymphoma risk in systemic lupus: effects of disease activity versus treatment","volume":"73","author":"S Bernatsky","year":"2014","journal-title":"Annals of the rheumatic diseases"},{"issue":"2","key":"pone.0243150.ref007","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/BOR.0000000000000026","article-title":"Incidence of lymphoma associated with underlying lupus: lessons learned from observational studies","volume":"26","author":"T Bichile","journal-title":"Current opinion in rheumatology"},{"issue":"5","key":"pone.0243150.ref008","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/BOR.0000000000000202","article-title":"Malignancies in systemic lupus erythematosus: a 2015 update","volume":"27","author":"GC Goobie","year":"2015","journal-title":"Current opinion in rheumatology"},{"issue":"3","key":"pone.0243150.ref009","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.berh.2017.09.013","article-title":"A review on SLE and malignancy","volume":"31","author":"MY Choi","year":"2017","journal-title":"Best practice & research Clinical rheumatology"},{"key":"pone.0243150.ref010","doi-asserted-by":"crossref","first-page":"6473204","DOI":"10.1155\/2016\/6473204","article-title":"Impaired Cytokine Responses to Epstein-Barr Virus Antigens in Systemic Lupus Erythematosus Patients","volume":"2016","author":"AH Draborg","year":"2016","journal-title":"Journal of immunology research"},{"issue":"1","key":"pone.0243150.ref011","doi-asserted-by":"crossref","first-page":"e000015","DOI":"10.1136\/lupus-2014-000015","article-title":"Reduced response to Epstein-Barr virus antigens by T-cells in systemic lupus erythematosus patients","volume":"1","author":"AH Draborg","year":"2014","journal-title":"Lupus science & medicine"},{"key":"pone.0243150.ref012","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.coviro.2016.09.006","article-title":"Malaria\u2014how this parasitic infection aids and abets EBV-associated Burkitt lymphomagenesis","volume":"20","author":"AM Moormann","journal-title":"Current opinion in virology"},{"issue":"3","key":"pone.0243150.ref013","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1177\/0961203309347921","article-title":"Diffuse large B-cell lymphoma of the central nervous system in mycophenolate mofetil-treated patients with systemic lupus erythematosus","volume":"19","author":"HH Tsang","year":"2010","journal-title":"Lupus"},{"issue":"5","key":"pone.0243150.ref014","first-page":"552","article-title":"Epstein-barr virus-associated non-Hodgkin's lymphoma of B-cell origin, Hodgkin's disease, acute leukemia, and systemic lupus erythematosus: a serologic and molecular analysis","volume":"85","author":"W Mitarnun","year":"2002","journal-title":"J Med Assoc Thai"},{"issue":"4","key":"pone.0243150.ref015","doi-asserted-by":"crossref","first-page":"R295","DOI":"10.1186\/ar1181","article-title":"Patients with systemic lupus erythematosus have abnormally elevated Epstein-Barr virus load in blood","volume":"6","author":"UY Moon","year":"2004","journal-title":"Arthritis research & therapy"},{"key":"pone.0243150.ref016","doi-asserted-by":"crossref","first-page":"189096","DOI":"10.1155\/2012\/189096","article-title":"CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis","volume":"2012","author":"MP Pender","year":"2012","journal-title":"Autoimmune diseases"},{"issue":"3","key":"pone.0243150.ref017","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ana.24009","article-title":"Multiple sclerosis: Prospects and promise","volume":"74","author":"SL Hauser","year":"2013","journal-title":"Annals of neurology"},{"issue":"13","key":"pone.0243150.ref018","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1212\/01.wnl.0000345366.10455.62","article-title":"Cancer risk among patients with multiple sclerosis and their parents","volume":"72","author":"S Bahmanyar","year":"2009","journal-title":"Neurology"},{"key":"pone.0243150.ref019","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.3389\/fimmu.2019.02954","article-title":"Multiple Sclerosis and Cancer: The Ying-Yang Effect of Disease Modifying Therapies","volume":"10","author":"E Melamed","year":"2019","journal-title":"Frontiers in immunology"},{"issue":"3","key":"pone.0243150.ref020","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1177\/1352458514564489","article-title":"A systematic review of the incidence and prevalence of cancer in multiple sclerosis","volume":"21","author":"RA Marrie","year":"2015","journal-title":"Mult Scler"},{"issue":"11","key":"pone.0243150.ref021","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1002\/acr.23553","article-title":"Phenome-Wide Association Studies Uncover a Novel Association of Increased Atrial Fibrillation in Male Patients With Systemic Lupus Erythematosus","volume":"70","author":"A Barnado","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"pone.0243150.ref022","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/acr.22989","article-title":"Developing Electronic Health Record Algorithms That Accurately Identify Patients With Systemic Lupus Erythematosus","volume":"69","author":"A Barnado","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"e2","key":"pone.0243150.ref023","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1136\/amiajnl-2013-001999","article-title":"Automated extraction of clinical traits of multiple sclerosis in electronic medical records","volume":"20","author":"MF Davis","year":"2013","journal-title":"J Am Med Inform Assoc"},{"issue":"4","key":"pone.0243150.ref024","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s10067-009-1332-7","article-title":"Incidence of cancer among female patients with systemic lupus erythematosus in Korea","volume":"29","author":"KY Kang","year":"2010","journal-title":"Clin Rheumatol"},{"key":"pone.0243150.ref025","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jaut.2012.12.009","article-title":"Cancer risk in systemic lupus: an updated international multi-centre cohort study","volume":"42","author":"S Bernatsky","year":"2013","journal-title":"J Autoimmun"},{"issue":"1732","key":"pone.0243150.ref026","article-title":"Epstein-Barr virus-associated lymphomas","volume":"372","author":"C Shannon-Lowe","year":"2017","journal-title":"Philosophical transactions of the Royal Society of London Series B, Biological sciences."},{"issue":"1\u20132","key":"pone.0243150.ref027","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jns.2009.03.028","article-title":"Epstein-Barr virus and multiple sclerosis","volume":"286","author":"D. Pohl","year":"2009","journal-title":"J Neurol Sci"},{"issue":"4","key":"pone.0243150.ref028","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1080\/08916930802024772","article-title":"Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases","volume":"41","author":"HH Niller","year":"2008","journal-title":"Autoimmunity"},{"issue":"12","key":"pone.0243150.ref029","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.3390\/v4123701","article-title":"Epstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis-association and causation","volume":"4","author":"A Lossius","year":"2012","journal-title":"Viruses"},{"issue":"4","key":"pone.0243150.ref030","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/BOR.0b013e3283535801","article-title":"Lupus and Epstein-Barr","volume":"24","author":"JA James","year":"2012","journal-title":"Current opinion in rheumatology"},{"issue":"3","key":"pone.0243150.ref031","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00296-003-0420-2","article-title":"Reactivation of Epstein-Barr virus in patients with systemic lupus erythematosus","volume":"25","author":"ML Huggins","year":"2005","journal-title":"Rheumatol Int"},{"key":"pone.0243150.ref032","doi-asserted-by":"crossref","first-page":"370516","DOI":"10.1155\/2012\/370516","article-title":"Epstein-Barr virus and systemic lupus erythematosus","volume":"2012","author":"AH Draborg","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"pone.0243150.ref033","article-title":"Aberrant Epstein-Barr viral infection in systemic lupus erythematosus","author":"BD Poole","year":"2009","journal-title":"Autoimmunity reviews"},{"issue":"3","key":"pone.0243150.ref034","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1177\/0961203316664595","article-title":"Breast cancer in systemic lupus","volume":"26","author":"S Bernatsky","year":"2017","journal-title":"Lupus"},{"issue":"2","key":"pone.0243150.ref035","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s10549-015-3412-5","article-title":"Comparison of breast cancer risk in women with and without systemic lupus erythematosus in a Medicare population","volume":"151","author":"W Khaliq","year":"2015","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"pone.0243150.ref036","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1002\/ijc.25956","article-title":"Prostate cancer in systemic lupus erythematosus","volume":"129","author":"S Bernatsky","year":"2011","journal-title":"International journal of cancer"},{"issue":"6","key":"pone.0243150.ref037","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/ijc.31148","article-title":"Autoimmune diseases and breast cancer risk by tumor hormone-receptor status among elderly women","volume":"142","author":"C Schairer","year":"2018","journal-title":"International journal of cancer"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0243150","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T22:51:12Z","timestamp":1611355872000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0243150"}},"subtitle":[],"editor":[{"given":"Maria Lina","family":"Tornesello","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,1,22]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0243150","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,22]]}}}